Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
4(29%)
Results Posted
14%(1 trials)

Phase Distribution

Ph early_phase_1
2
14%
Ph phase_2
2
14%
Ph phase_1
2
14%
Ph phase_3
3
21%
Ph phase_4
4
29%

Phase Distribution

4

Early Stage

2

Mid Stage

7

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
2(15.4%)
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
4(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Active, not recruiting3
Withdrawn2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (15.4%)
Phase 12 (15.4%)
Phase 22 (15.4%)
Phase 33 (23.1%)
Phase 44 (30.8%)

Trials by Status

active_not_recruiting321%
withdrawn214%
unknown17%
completed750%
recruiting17%

Recent Activity

4 active trials
Showing 5 of 14
completedphase_3

Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage

NCT04362527
active_not_recruitingphase_1

Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

NCT03153319
active_not_recruitingphase_1

Hormonal Mechanisms of Sleep Restriction - Axis Study

NCT03142893
active_not_recruitingearly_phase_1

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

NCT04037605
recruitingearly_phase_1

Lidocaine Infusion in Pancreatic Cancer

NCT04048278
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT04362527Phase 3

Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage

Completed
NCT03153319Phase 1

Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

Active Not Recruiting
NCT03142893Phase 1

Hormonal Mechanisms of Sleep Restriction - Axis Study

Active Not Recruiting
NCT04037605Early Phase 1

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

Active Not Recruiting
NCT04048278Early Phase 1

Lidocaine Infusion in Pancreatic Cancer

Recruiting
NCT03074591Phase 4

Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction

Completed
NCT03874936Phase 2

The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.

Completed
NCT03769714Phase 4

EXPAREL for Minimally Invasive Supracervical Hysterectomies

Completed
NCT03745664Phase 3

Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)

Unknown
NCT03506620Phase 4

The Role of Nerve Blocks in Hip Arthroscopy

Withdrawn
NCT03508882Phase 4

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm

Completed
NCT03544073Phase 3

GnRH Agonist at Embryo Transfer: IVF Outcomes

Withdrawn
NCT03694717

Time Course Evolution of Cardiac Output

Completed
NCT01280344Phase 2

Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14